Cheryl Abbas

613 total citations · 1 hit paper
15 papers, 389 citations indexed

About

Cheryl Abbas is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cheryl Abbas has authored 15 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cheryl Abbas's work include Heart Failure Treatment and Management (7 papers), Lipoproteins and Cardiovascular Health (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Cheryl Abbas is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Lipoproteins and Cardiovascular Health (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Cheryl Abbas collaborates with scholars based in United States, Switzerland and India. Cheryl Abbas's co-authors include Scott D. Solomon, Akshay S. Desai, Joseph L. Izzo, Amil M. Shah, James C. Fang, Brian Claggett, Ricardo Rocha, Gary F. Mitchell, Javed Butler and G. Michael Felker and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Cheryl Abbas

13 papers receiving 384 citations

Hit Papers

Effect of Sacubitril-Valsartan vs Enalapril on Aortic Sti... 2019 2026 2021 2023 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
    2019 224 citations Akshay S. Desai, Scott D. Solomon et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Abbas United States 7 312 81 68 64 23 15 389
Wei-Hsian Yin Taiwan 8 155 0.5× 133 1.6× 60 0.9× 25 0.4× 26 1.1× 28 300
Tadaaki Arimura Japan 9 243 0.8× 62 0.8× 47 0.7× 25 0.4× 8 0.3× 36 324
Pascal Meyre Switzerland 11 316 1.0× 55 0.7× 25 0.4× 24 0.4× 33 1.4× 33 405
Xueyuan Guo China 13 509 1.6× 60 0.7× 21 0.3× 30 0.5× 33 1.4× 69 605
Łukasz Januszkiewicz Poland 9 183 0.6× 133 1.6× 112 1.6× 36 0.6× 32 1.4× 22 337
J.‐C. Tardif Canada 11 318 1.0× 197 2.4× 29 0.4× 66 1.0× 19 0.8× 24 493
Wilhelm Ridderstråle Sweden 8 239 0.8× 150 1.9× 65 1.0× 20 0.3× 16 0.7× 14 322
Stephen Hippler United States 5 245 0.8× 52 0.6× 93 1.4× 21 0.3× 16 0.7× 7 399
Dong Dai China 7 112 0.4× 32 0.4× 90 1.3× 38 0.6× 5 0.2× 13 247
Aristi Boulmpou Greece 10 132 0.4× 53 0.7× 76 1.1× 23 0.4× 10 0.4× 49 251

Countries citing papers authored by Cheryl Abbas

Since Specialization
Citations

This map shows the geographic impact of Cheryl Abbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Abbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Abbas more than expected).

Fields of papers citing papers by Cheryl Abbas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Abbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Abbas. The network helps show where Cheryl Abbas may publish in the future.

Co-authorship network of co-authors of Cheryl Abbas

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Abbas. A scholar is included among the top collaborators of Cheryl Abbas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Abbas. Cheryl Abbas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Knowlton, Kirk U., Ann Marie Návar, Jeffrey Anderson, et al.. (2025). LDL-C management with inclisiran plus usual care vs usual care alone in participants with recent acute coronary syndrome: VICTORION-INCEPTION. Journal of clinical lipidology. 19(3). e109–e110. 2 indexed citations
2.
Shapiro, Michael D., Howard Weintraub, Seth J. Baum, et al.. (2024). Lipoprotein(a) levels in a population with clinical atherosclerotic cardiovascular disease in the United States: A subanalysis from the Lp(a)HERITAGE study. Journal of clinical lipidology. 19(1). 28–38. 2 indexed citations
3.
Kamstrup, Pia R., R. Dermot G. Neely, Steven E. Nissen, et al.. (2024). Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research. European Journal of Preventive Cardiology. 31(7). 903–914. 15 indexed citations
4.
Koren, Michael, Fátima Rodríguez, Cara East, et al.. (2024). An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology. 83(20). 1939–1952. 37 indexed citations
5.
6.
Hu, Xiao, Cheryl Abbas, Sue Richardson, et al.. (2023). Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy. European Journal of Cardiovascular Nursing. 22(Supplement_1). 2 indexed citations
7.
Shapiro, Michael D., Howard Weintraub, Seth J. Baum, et al.. (2023). LIPOPROTEIN(A) LEVELS IN POPULATION WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN THE UNITED STATES: A SUBANALYSIS FROM THE LP(A)HERITAGE STUDY. Journal of the American College of Cardiology. 81(8). 1633–1633. 6 indexed citations
8.
Murphy, Sean, Margaret F. Prescott, Alexander Camacho, et al.. (2020). Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 9(2). 127–136. 54 indexed citations
9.
Ibrahim, Nasrien E., Ileana L. Piña, Alexander Camacho, et al.. (2020). Sex-Based Differences in Biomarkers, Health Status, and Reverse Cardiac Remodelling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/Valsartan. European Journal of Heart Failure. 22(11). 2018–2025. 20 indexed citations
10.
Ibrahim, Nasrien E., Ileana L. Piña, Alexander Camacho, et al.. (2020). Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan. Circulation Heart Failure. 13(11). e007829–e007829. 15 indexed citations
11.
Murphy, Sean, Margaret F. Prescott, Alexander Camacho, et al.. (2020). Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction. Journal of Cardiac Failure. 26(10). S15–S15.
12.
Desai, Akshay S., Amil M. Shah, Gary F. Mitchell, et al.. (2019). Abstract 14392: Effects of Sacubitril-Valsartan Compared With Enalapril on Pulmonary Artery Pressure in Patients With Heart Failure and Reduced Ejection Fraction. Circulation. 1 indexed citations
13.
Desai, Akshay S., Scott D. Solomon, Amil M. Shah, et al.. (2019). Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction. JAMA. 322(11). 1077–1077. 224 indexed citations breakdown →
14.
Tanaka, Daizo, et al.. (2015). Low-dose Vitamin K can Improve Warfarin Control in Patients on LVAD Support. UKnowledge (University of Kentucky). 1(1). 21.
15.
Hussar, Daniel A. & Cheryl Abbas. (2010). New drugs: Asenapine, iloperidone, and bepotastine besilate. Journal of the American Pharmacists Association. 50(1). 107–110. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei-Hsian Yin Breakdown of academic impact, for papers by Tadaaki Arimura Breakdown of academic impact, for papers by Pascal Meyre Breakdown of academic impact, for papers by Xueyuan Guo Breakdown of academic impact, for papers by Łukasz Januszkiewicz Breakdown of academic impact, for papers by J.‐C. Tardif Breakdown of academic impact, for papers by Wilhelm Ridderstråle Breakdown of academic impact, for papers by Stephen Hippler Breakdown of academic impact, for papers by Dong Dai Breakdown of academic impact, for papers by Aristi Boulmpou
Rankless by CCL
2026